Staphylococcus aureus

BacteriaBacillotaBacilliStaphylococcalesStaphylococcaceaeStaphylococcus
Synonyms: Micrococcus aureus
MCA-BAC-000051
TaxID: 1280 | BacDive: 14487 | Rank: species
Biology & Ecology
Biology
Gram Statusgram-positive
Oxygen Tolerancefacultative anaerobe
Morphologycoccus
Key Traits
  • catalase-positive
  • coagulase-positive
  • non-motile
  • non-spore-forming
Ecology
Reservoiranimal, human
Transmission
  • fecal-oral
  • healthcare-associated
Metabolites

No metabolite relationships documented for this taxon.

Clinical Profile
Pathobiont
yes no context dependent unknown
Clinical Rolesprimary pathogen
Typical Specimenblood; stool
Bloom Triggers D00929 antibiotic exposure
Risk Contextsbacteremia; ICU / critical care
AMR Highlights 3004306 MRSA
Virulence Factors VF0001 alpha-hemolysin (Hla) · VF0002 beta-hemolysin (Hlb) · VF0007 delta-hemolysin (Hld) · VF0011 gamma-hemolysin (Hlg) · VF0018 Panton-Valentine leukocidin (PVL) · VF0020 staphylococcal enterotoxin (SE) · VF0017 staphylococcal protein A (SpA)
Clinical Associations:
E1
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
Staphylococcus aureus disseminates from the bloodstream to the gastrointestinal tract following bacteremia and is shed in feces at high titres, establishing a reservoir for fecal-oral transmission in a murine intravenous infection model.
PMID: 25385792
D016470 Bacteremia D041981 Gastrointestinal Tract D013203 Staphylococcal Infections
E1
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
Fecal-oral transmission of S. aureus from bacteremic donor mice to naive cage-mates requires intact agr quorum-sensing and sae two-component regulatory systems; agr+sae double-mutant strains show approximately 10³-fold reduction in transmission efficiency (n=6 recipient mice per group).
PMID: 25385792
D041981 Gastrointestinal Tract D013203 Staphylococcal Infections
E1
E3 — Strong human clinical evidence E2 — Moderate human evidence E1 — Limited / preliminary
In mixed MRSA/MSSA infections in oxacillin-treated mice, MRSA is selectively transmitted to antibiotic-naive recipient mice via the fecal-oral route, demonstrating that antibiotic exposure drives selective spread of resistant strains through the GI reservoir (n=6 recipients).
PMID: 25385792
D024881 Drug Resistance, Bacterial D013203 Staphylococcal Infections H00330 MRSA infection
Last reviewed: 2026-04-03
Evidence Timeline
Related Taxa Shared Niche = same body site   Shared Risk = same vulnerable population